OBJECTIVES: del Nido cardioplegia is used to pharmacologically arrest the heart during cardiac surgery and decrease reperfusion- and ischaemia-related myocardial injury. Studies have demonstrated the physiological differences between male and female hearts, potentially related to cardiac size or myocyte calcium handling; we aimed to assess for between-sex differences in clinical outcomes after receipt of del Nido cardioplegia. METHODS: Patients who underwent coronary artery bypass or coronary artery bypass graft/valve surgery at our institution using del Nido cardioplegia (January 2014 to December 2019) were included (n = 2118). Clinical data were collected retrospectively. After the creation of a propensity-matched cohort (n = 1252), multivariable logistic regression was used to analyse binary postoperative outcomes, and a Gamma model was used for a continuous postoperative outcome. Our primary end-point was a composite end-point comprised of 30-day mortality and/or need for a post-bypass mechanical support device. RESULTS: The final cohort included 459 females and 793 males (matched up to 1:2, all standardized mean differences <0.1). Multivariable logistic regression showed that biological sex was not associated with the composite primary end-point (odds ratio = 0.898, P = 0.779). A Gamma model indicated that there were no sex-related differences in vasoactive-inotropic scores reflecting vasopressor and inotrope usage at the time of patient operating room exit (exp[est] = 1.394, P = 0.189). CONCLUSIONS: Our findings showed no significant between-sex differences in clinical outcomes after receiving del Nido cardioplegia, suggesting adequate myocardial protection as currently administered. Further research is warranted to elicit if there are sex-based differences between cardioplegic solutions. IRB APPROVAL DATE (PROTOCOL NUMBER): 26 May 2021 (AAAR8359).
OBJECTIVES: del Nido cardioplegia is used to pharmacologically arrest the heart during cardiac surgery and decrease reperfusion- and ischaemia-related myocardial injury. Studies have demonstrated the physiological differences between male and female hearts, potentially related to cardiac size or myocyte calcium handling; we aimed to assess for between-sex differences in clinical outcomes after receipt of del Nido cardioplegia. METHODS: Patients who underwent coronary artery bypass or coronary artery bypass graft/valve surgery at our institution using del Nido cardioplegia (January 2014 to December 2019) were included (n = 2118). Clinical data were collected retrospectively. After the creation of a propensity-matched cohort (n = 1252), multivariable logistic regression was used to analyse binary postoperative outcomes, and a Gamma model was used for a continuous postoperative outcome. Our primary end-point was a composite end-point comprised of 30-day mortality and/or need for a post-bypass mechanical support device. RESULTS: The final cohort included 459 females and 793 males (matched up to 1:2, all standardized mean differences <0.1). Multivariable logistic regression showed that biological sex was not associated with the composite primary end-point (odds ratio = 0.898, P = 0.779). A Gamma model indicated that there were no sex-related differences in vasoactive-inotropic scores reflecting vasopressor and inotrope usage at the time of patient operating room exit (exp[est] = 1.394, P = 0.189). CONCLUSIONS: Our findings showed no significant between-sex differences in clinical outcomes after receiving del Nido cardioplegia, suggesting adequate myocardial protection as currently administered. Further research is warranted to elicit if there are sex-based differences between cardioplegic solutions. IRB APPROVAL DATE (PROTOCOL NUMBER): 26 May 2021 (AAAR8359).
Authors: Timo Koponen; Johanna Karttunen; Tadeusz Musialowicz; Laura Pietiläinen; Ari Uusaro; Pasi Lahtinen Journal: Br J Anaesth Date: 2019-02-18 Impact factor: 9.166
Authors: Ivancarmine Gambardella; Mario F L Gaudino; George A Antoniou; Mohamad Rahouma; Berhane Worku; Robert F Tranbaugh; Francesco Nappi; Leonard N Girardi Journal: J Thorac Cardiovasc Surg Date: 2019-09-05 Impact factor: 5.209
Authors: Krzysztof Sanetra; Wojciech Domaradzki; Marek Cisowski; Krzysztof Białek; Rajesh Shrestha; Andrzej Bochenek; Justyna Jankowska-Sanetra; Piotr P Buszman; Witold Gerber Journal: J Cardiovasc Surg (Torino) Date: 2021-06-09 Impact factor: 1.888
Authors: Yang Cao; Laurent Vergnes; Yu-Chen Wang; Calvin Pan; Karthickeyan Chella Krishnan; Timothy M Moore; Manuel Rosa-Garrido; Todd H Kimball; Zhiqiang Zhou; Sarada Charugundla; Christoph D Rau; Marcus M Seldin; Jessica Wang; Yibin Wang; Thomas M Vondriska; Karen Reue; Aldons J Lusis Journal: Nat Commun Date: 2022-07-04 Impact factor: 17.694